Phase 1 trial of vorolanib plus everolimus for advanced kidney cancer By Sharon Kell|2020-05-11T08:55:40+00:0011 May 2020|Uncategorized| A new combination of vorolanib, a tyrosine kinase inhibitor plus [...] Read More Comments Off on Phase 1 trial of vorolanib plus everolimus for advanced kidney cancer